Molecule Details
InChIKeyZJVFLBOZORBYFE-UHFFFAOYSA-N
Compound NameIbudilast
Canonical SMILESCC(C)C(=O)c1c(C(C)C)nn2ccccc12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Homologous
Avg pChEMBL6.97
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB05266
Drug NameIbudilast
CAS Number50847-11-5
Groups investigational
ATC Codes R03DC04
DescriptionIbudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple ...

Categories: Anti-Asthmatic Agents Antiplatelet agents Autonomic Agents Bronchodilator Agents Cardiovascular Agents Drugs for Obstructive Airway Diseases Enzyme Inhibitors Hematologic Agents Heterocyclic Compounds, Fused-Ring Leukotriene Antagonists Peripheral Nervous System Agents Phosphodiesterase 5 Inhibitors Phosphodiesterase Inhibitors Respiratory System Agents Vasodilating Agents
Cross-references: BindingDB: 50240404 ChEBI: 31684 CHEMBL19449 ChemSpider: 3543 PDB: AVL PharmGKB: PA165958351 PubChem:3671 PubChem:99443231 Wikipedia: Ibudilast ZINC: ZINC000000004234
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P27815 PDE4A Homo sapiens Human PF18100 PF00233 7.3 IC50 ChEMBL;BindingDB
Q07343 PDE4B Homo sapiens Human PF18100 PF00233 7.2 IC50 ChEMBL;BindingDB
Q08499 PDE4D Homo sapiens Human PF18100 PF00233 6.8 IC50 ChEMBL;BindingDB
Q08493 PDE4C Homo sapiens Human PF18100 PF00233 6.6 IC50 ChEMBL;BindingDB
DrugBank Target Actions (5)
Target Gene Target Name Action Type
P27815 PDE4A 3',5'-cyclic-AMP phosphodiesterase 4A inhibitor targets
Q07343 PDE4B 3',5'-cyclic-AMP phosphodiesterase 4B inhibitor targets
Q08493 PDE4C 3',5'-cyclic-AMP phosphodiesterase 4C inhibitor targets
Q08499 PDE4D 3',5'-cyclic-AMP phosphodiesterase 4D inhibitor targets
Q14432 PDE3A cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A inhibitor targets